Bu sayfada
01PRGO fiyat
02Anlık Görüntü
03Grafik
04Hisse bölünmeleri
05Hakkında
06Performans
07Değerleme ve oranlar
13Temettüler
14Kazançlar
15Tüm Temeller
16Finansal Tablolar
17Kurumsal Sahipler (13F)
18Aktivistler ve %5+ sahipler
19Şirket yöneticileri
20ETF sahipliği
21Konsensüs
22Akranlar
23Haberler
26Metriklerim
PRGO Perrigo Company plc Ordinary Shares
NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$14,26
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$9,2352 haftanın en düşüğü
$22,6552 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.98B
P/E (TTM)
-1.1
Hisse Başına Kâr (TTM)
$-12.52
Gelir (TTM)
$4.14B
rozetleriniz
52 Haftlık Aralık
$9–$23
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$16
P/E
-1.1
ROE
-49.6%
Net Kâr Marjı
-41.9%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PRGO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$14.26
Piyasa Değeri (MRQ)
$1.98B
P/E (TTM)
-1.1
Hisse Başına Kâr (TTM)
$-12.52
Gelir (TTM)
$4.14B
Temettü Verimi
8.1%
ROE (TTM)
-49.6%
D/E Borç/Özsermaye (MRQ)
1.3
52 Haftlık Aralık
$9–$23
PRGO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 26 Ağustos 1993 | 2-for-1 | İleri |
Perrigo Company plc Ordinary Shares Hakkında Wikipedia'dan şirket genel bakışı
Perrigo Company plc, İrlanda ve Amerika Birleşik Devletleri merkezli bir ilaç şirketidir. Şirket, 1887 yılında Luther ve Charles Perrigo tarafından kurulmuş olup özel markalı reçetesiz ilaç üretimim yapmaktadır. Şirketin merkezi Dublin ve Michigan eyaletine bağlı Allegan kasabasında yer almaktadır.
Perrigo, İrlanda'daki merkezinden başta Amerika Birleşik Devletleri olmak üzere tüketici sağlık ürünleri, jenerik reçeteli ilaçlar ve aktif farmasötik bileşenlerin satın alınması, üretimi ve satışı ile ilgilenmektedir.
Kaynakça
Dış bağlantılar
Resmî site
Kaynak: Wikipedia, CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriPharmaceuticals
çalışanlar8.100
ülkeIE
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$4.25B2017-12-31 → 2025-12-31
Hisse Başına Kâr$-10.292017-12-31 → 2025-12-31
Serbest Nakit Akışı$145M2017-12-31 → 2025-12-31
Net kar marjı-41.9%2017-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PRGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15Y ort. ≈-103.1 | ≈-103.1 | · | · | |
| F/S (TTM) | 0.55Y ort. ≈0.7 | ≈0.7 | · | · | |
| F/D (MRQ) | 0.85Y ort. ≈0.8 | ≈0.8 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | 16.65Y ort. ≈14.0 | ≈14.0 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 10.15Y ort. ≈9.5 | ≈9.5 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -1.0 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PRGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 33.3%5Y ort. ≈34.8% | ≈34.8% | · | · | |
| Faaliyet Kâr Marjı (TTM) | -37.7%5Y ort. ≈-4.7% | ≈-4.7% | · | · | |
| FAVÖK Marjı (TTM) | -29.3%5Y ort. ≈3.0% | ≈3.0% | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | -38.9%5Y ort. ≈-10.8% | ≈-10.8% | · | · | |
| Net Kâr Marjı (TTM) | -41.9%5Y ort. ≈-10.2% | ≈-10.2% | · | · | |
| ROA (TTM) | -19.6%5Y ort. ≈-4.7% | ≈-4.7% | · | · | |
| ROE (TTM) | -49.6%5Y ort. ≈-11.4% | ≈-11.4% | · | · | |
| ROIC | -18.4%5Y ort. ≈-4.9% | ≈-4.9% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PRGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 1.35Y ort. ≈0.9 | ≈0.9 | · | · | |
| Cari Oran (MRQ) | 2.35Y ort. ≈2.3 | ≈2.3 | · | · | |
| Quick Ratio (Cari Oran) | 0.65Y ort. ≈0.7 | ≈0.7 | · | · | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 1.35Y ort. ≈0.9 | ≈0.9 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PRGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -2.8%5Y ort. ≈0.83% | ≈0.83% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -1.5%5Y ort. ≈1.6% | ≈1.6% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 0.79% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PRGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.55Y ort. ≈0.4 | ≈0.4 | · | · | |
| Inventory Turnover (Stok Devir Hızı) | 2.55Y ort. ≈2.6 | ≈2.6 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 6.85Y ort. ≈6.5 | ≈6.5 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$525.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi8.1%
Temettü Ödeme Oranı-11.2%
Yıllıklaştırılmış Ödeme≈$1.16
5 Yıllık Temettü CAGR≈5.2%
Büyüme Serisi≈21
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Ağu 28, 2026 | $0,29 | USD | ≈8.0% |
| May 29, 2026 | $0,29 | USD | ≈10.5% |
| Mar 2, 2026 | $0,29 | USD | ≈9.4% |
| Ağu 29, 2025 | $0,29 | USD | ≈4.8% |
| May 30, 2025 | $0,29 | USD | ≈4.2% |
| Mar 7, 2025 | $0,29 | USD | ≈4.0% |
| Kas 29, 2024 | $0,28 | USD | ≈3.9% |
| Ağu 30, 2024 | $0,28 | USD | ≈3.8% |
| May 31, 2024 | $0,28 | USD | ≈4.0% |
| Mar 7, 2024 | $0,28 | USD | ≈3.7% |
| Kas 30, 2023 | $0,27 | USD | ≈3.6% |
| Ağu 31, 2023 | $0,27 | USD | ≈3.1% |
| Haz 1, 2023 | $0,27 | USD | ≈3.3% |
| Mar 9, 2023 | $0,27 | USD | ≈2.9% |
| Ara 1, 2022 | $0,26 | USD | ≈3.2% |
| Eyl 1, 2022 | $0,26 | USD | ≈2.8% |
| Haz 2, 2022 | $0,26 | USD | ≈2.5% |
| Şub 25, 2022 | $0,26 | USD | ≈2.7% |
| Ara 2, 2021 | $0,24 | USD | ≈2.7% |
| Eyl 2, 2021 | $0,24 | USD | ≈2.3% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
13.7%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $0.50 | $0.35 | 43.2% |
| 31 Mart 2026 | May 12, 2026 | $0.43 | $0.32 | 34.5% |
| 31 Aralık 2025 | $0.79 | $0.80 | -1.4% | |
| 30 Eylül 2025 | $0.80 | $0.77 | 4.0% | |
| 30 Haziran 2025 | $0.57 | $0.61 | -5.8% | |
| 31 Mart 2025 | $0.60 | $0.56 | 7.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B | $4.09B | $3.87B | $4.73B | $4.95B | $5.28B | · | |
| Cost of Revenue | $2.76B | $2.83B | $2.98B | $3.00B | $2.72B | $2.59B | $2.44B | $2.90B | $2.97B | $3.23B | · | |
| Gross Profit | $1.49B | $1.54B | $1.68B | $1.46B | $1.42B | $1.49B | $1.43B | $1.83B | $1.98B | $2.05B | · | |
| R&D Expense | $95M | $112M | $122M | $123M | $122M | $122M | $119M | $219M | $168M | $184M | · | |
| SG&A Expense | $436M | $468M | $522M | $512M | $482M | $478M | $476M | $436M | $461M | $452M | · | |
| Operating Expenses | $2.62B | $1.43B | $1.53B | $1.38B | $1.01B | $1.23B | $1.26B | $1.59B | $1.38B | $4.05B | · | |
| Operating Income | $-1.12B | $113M | $152M | $79M | $410M | $265M | $175M | $236M | $598M | $-2.00B | · | |
| Other Non-op | $-13M | $900.0K | $10M | $-53M | $-27M | $-16M | $69M | $-6M | $10M | $-23M | · | |
| Pretax Income | $-1.30B | $-81M | $-8M | $-139M | $259M | · | · | $291M | $280M | $-4.85B | · | |
| Income Tax | $104M | $80M | $-4M | $-8M | $390M | $-38M | $-11M | $160M | $160M | $-836M | · | |
| Net Income | $-1.43B | $-172M | $-13M | $-141M | $-69M | $-163M | $146M | $131M | $120M | $-4.01B | · | |
| EPS (Basic) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 | $-1.20 | $1.07 | $0.95 | $0.84 | $-28.01 | · | |
| EPS (Diluted) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 | $-1.19 | $1.07 | $0.95 | $0.84 | $-28.01 | · | |
| Shares (Basic) | 138,500,000 | 137,400,000 | 135,300,000 | 134,500,000 | 133,600,000 | 136,100,000 | 136,000,000 | 137,800,000 | 142,300,000 | 143,300,000 | · | |
| Shares (Diluted) | 138,500,000 | 137,400,000 | 135,300,000 | 134,500,000 | 133,600,000 | 137,200,000 | 136,500,000 | 138,300,000 | 142,600,000 | 143,300,000 | · | |
| EBITDA | $-785M | $439M | $511M | $418M | $723M | $500M | $601M | $660M | $1.04B | $-1.54B | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $559M | $751M | $601M | $1.86B | $632M | $354M | $551M | $679M | $622M | $418M | |
| Receivables | $613M | $642M | $740M | $697M | $653M | $594M | $1.24B | $1.07B | $1.13B | $1.18B | $1.19B | |
| Inventory | $1.15B | $1.08B | $1.14B | $1.15B | $1.02B | $1.06B | $967M | $878M | $807M | $795M | $899M | |
| Prepaid Expense | $231M | $199M | $201M | $272M | $306M | $182M | $166M | $400M | $203M | $212M | $286M | |
| Current Assets | $2.80B | $2.48B | $2.83B | $2.72B | $3.86B | $3.13B | $2.73B | $2.90B | $2.82B | $2.81B | $2.79B | |
| PP&E (Net) | $899M | $918M | $916M | $926M | $864M | $865M | $774M | $829M | $833M | $870M | $886M | |
| PP&E (Gross) | · | · | · | · | $1.78B | $1.73B | $1.82B | $1.68B | $1.64B | $1.66B | $1.66B | |
| Accum. Depreciation | · | · | · | · | $912M | $861M | $922M | $852M | $805M | $790M | $773M | |
| Goodwill | $2.05B | $3.32B | $3.53B | $3.49B | $3.00B | $3.10B | $3.10B | $3.98B | $4.18B | $4.05B | $5.15B | |
| Intangibles | $4.76B | $4.50B | $5.00B | $5.01B | $3.68B | $3.89B | $4.75B | $4.43B | $4.75B | $4.53B | $5.62B | |
| Other Non-current Assets | $262M | $319M | $335M | $368M | $378M | $347M | $426M | $363M | $410M | $212M | $248M | |
| Total Assets | $8.54B | $9.65B | $10.81B | $11.02B | $10.43B | $11.49B | $11.30B | $10.98B | $11.63B | $13.87B | $19.35B | |
| Accounts Payable | $474M | $495M | $478M | $537M | $411M | $452M | $520M | $475M | $450M | $472M | $556M | |
| Accrued Liabilities | · | $239M | $335M | $250M | $279M | $183M | $229M | $201M | $231M | $263M | $352M | |
| Current Liabilities | $1.01B | $1.04B | $1.59B | $1.11B | $1.59B | $1.38B | $1.34B | $1.54B | $1.44B | $1.84B | $2.55B | |
| Capital Leases | $152M | $154M | $160M | $190M | $147M | $132M | $102M | · | · | · | · | |
| Deferred Tax | $169M | $203M | $262M | $368M | $239M | $276M | $281M | $282M | $322M | $390M | $1.37B | |
| Other Non-current Liabilities | $814M | $499M | $560M | $623M | $530M | $539M | $515M | $443M | $430M | $462M | $346M | |
| Total Liabilities | $5.60B | $5.33B | $6.04B | $6.18B | $5.27B | $5.83B | $5.50B | $5.32B | $5.46B | $7.91B | $9.24B | |
| Long-term Debt | $3.64B | $3.62B | $4.07B | $4.11B | $3.52B | $3.56B | $3.37B | $3.24B | $3.34B | $5.80B | $6.03B | |
| Total Debt | $3.64B | $3.62B | $4.07B | $4.11B | $3.52B | $3.57B | $3.37B | $3.24B | · | $5.80B | · | |
| Common Stock | $6.61B | $6.73B | $6.84B | $6.94B | $7.04B | $7.12B | $7.36B | $7.42B | $7.89B | $8.13B | $8.14B | |
| Retained Earnings | $-3.68B | $-2.25B | $-2.08B | $-2.07B | $-1.93B | $-1.86B | $-1.70B | $-1.84B | $-1.98B | $-2.10B | $1.98B | |
| AOCI | $5M | $-162M | $11M | $-27M | $36M | $395M | $139M | $85M | $253M | $-82M | $-15M | |
| Stockholders' Equity | $2.94B | $4.32B | $4.77B | $4.84B | $5.15B | $5.66B | $5.80B | $5.67B | $6.17B | $5.96B | $10.11B | |
| Liabilities + Equity | $8.54B | $9.65B | $10.81B | $11.02B | $10.43B | $11.49B | $11.30B | $10.98B | $11.63B | $13.87B | $19.35B | |
| Shares Outstanding | 137,600,000 | 136,500,000 | 135,500,000 | 134,700,000 | · | · | · | · | 140,800,000 | 143,400,000 | 143,100,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $338M | $326M | $360M | $339M | $312M | $385M | $396M | $424M | $445M | $457M | · | |
| Stock-based Comp | $55M | $64M | $69M | $55M | $60M | $58M | $52M | $38M | $44M | $23M | · | |
| Deferred Tax | $-51M | $10M | $-107M | $-50M | $9M | $-54M | $-44M | $-18M | $-49M | $-991M | · | |
| Amort. of Intangibles | $223M | $228M | $266M | $252M | $210M | $212M | $220M | $334M | $350M | $357M | · | |
| Restructuring | $72M | $110M | $42M | $42M | $17M | $3M | $26M | $21M | $61M | $31M | · | |
| Other Non-cash | $1.22B | $60M | $38M | $125M | $-452M | $341M | $-477M | $-800.0K | $36M | $5.08B | · | |
| Operating Cash Flow | $238M | $363M | $406M | $307M | $156M | $636M | $388M | $593M | $699M | $655M | · | |
| CapEx | $93M | $118M | $102M | $96M | $152M | $170M | $138M | $103M | $89M | $106M | · | |
| Investing Cash Flow | $-75M | $79M | $-78M | $-1.96B | $1.28B | $-188M | $-596M | $-127M | $2.34B | $-175M | · | |
| Debt Issued | $0 | $1.09B | $295M | $1.59B | $0 | $744M | $600M | $431M | $0 | $1.19B | · | |
| Net Debt Issued | $-35M | $-438M | $-30M | $628M | $0 | $154M | $124M | $-52M | $-2.61B | $631M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $900.0K | $1M | $700.0K | $8M | · | |
| Stock Repurchased | · | · | · | $0 | $0 | $164M | $0 | $400M | $192M | $0 | · | |
| Net Stock Activity | · | · | · | $0 | $0 | $-164M | $900.0K | $-399M | $-191M | $8M | · | |
| Dividends Paid | $159M | $152M | $150M | $142M | $130M | $124M | $112M | $105M | $91M | $83M | · | |
| Financing Cash Flow | $-220M | $-611M | $-187M | $422M | $-179M | $-181M | $2M | $-572M | $-3.00B | $-269M | · | |
| Net Change in Cash | $-25M | $-192M | $151M | $-1.28B | $1.24B | $287M | $-197M | $-128M | $56M | $204M | · | |
| Taxes Paid | $79M | $153M | $97M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $145M | $245M | $304M | $211M | $4M | $466M | $250M | $490M | $610M | $549M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | 35.3% | 36.1% | 32.7% | 34.2% | 35.9% | 36.7% | 38.7% | 40.0% | 38.9% | · | |
| Operating Margin | -26.4% | 2.6% | 3.3% | 1.8% | 9.9% | 2.3% | 4.2% | 5.0% | 12.1% | -37.9% | · | |
| Net Margin | -33.5% | -3.9% | -0.27% | -3.2% | -1.7% | -3.2% | 3.0% | 2.8% | 2.4% | -76.0% | · | |
| Pretax Margin | -30.5% | -1.8% | -0.18% | · | · | · | · | 6.1% | 5.7% | -91.8% | · | |
| EBITDA Margin | -18.4% | 10.0% | 11.0% | 9.4% | 17.5% | 9.9% | 12.4% | 14.0% | 21.1% | -29.2% | · | |
| ROA | -15.7% | -1.7% | -0.12% | -1.3% | -0.63% | -1.4% | 1.3% | 1.2% | · | -24.2% | · | |
| ROE | -38.5% | -3.9% | -0.27% | -3.0% | -1.3% | -2.8% | 2.5% | 2.3% | · | -50.0% | · | |
| ROIC | -18.4% | 2.8% | 0.91% | · | · | · | · | 1.2% | · | -14.1% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.4 | 1.8 | 2.4 | 2.4 | 2.3 | 2.1 | 1.9 | · | 1.5 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.5 | 1.2 | 1.6 | 1.2 | 1.2 | 1.1 | · | 1.0 | · | |
| Debt / Equity | 1.2 | 0.8 | 0.9 | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | · | 1.0 | · | |
| LT Debt / Equity | 1.2 | 0.8 | 0.8 | 0.8 | 0.6 | 0.6 | 0.6 | 0.5 | · | 0.9 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | · | 0.3 | · | |
| Inventory Turnover | 2.5 | 2.5 | 2.6 | 2.8 | 2.6 | 3.0 | 3.3 | 3.4 | · | 3.8 | · | |
| Receivables Turnover | 6.8 | 6.3 | 6.5 | 6.5 | 6.6 | 4.4 | 4.2 | 4.3 | · | 4.5 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.33 | $31.64 | $35.19 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $30.71 | $31.83 | $34.41 | $33.10 | $30.98 | $37.20 | $35.44 | $34.21 | $34.69 | $36.85 | · | |
| Cash Flow / Share | $1.72 | $2.64 | $3.00 | $2.28 | $1.17 | $4.67 | $2.84 | $4.29 | $4.90 | $4.57 | · | |
| Dividend / Share | $1.16 | $1.10 | $1.09 | $1.04 | $0.96 | $0.90 | $0.82 | $0.76 | $0.64 | $0.58 | · | |
| EPS (TTM) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 | $-1.19 | $1.07 | $0.95 | $0.84 | $-28.01 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.8% | -6.1% | 4.6% | 7.6% | 1.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.5% | 1.9% | 4.4% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.79% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B | $4.09B | $3.87B | $4.73B | $4.95B | $5.28B | · | |
| Net Income TTM | $-1.43B | $-172M | $-13M | $-141M | $-69M | $-163M | $146M | $131M | $120M | $-4.01B | · | |
| Market Cap | $1.92B | $3.51B | $4.36B | · | · | · | · | · | · | · | · | |
| P/E | -1.4 | -20.6 | -357.6 | -32.8 | -74.8 | -37.6 | 48.3 | 40.8 | 103.8 | -3.0 | · | |
| P/S | 0.5 | 0.8 | 0.9 | · | · | · | · | · | · | · | · | |
| P/B | 0.7 | 0.8 | 0.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.0 | 9.7 | 10.8 | · | · | · | · | · | · | · | · | |
| P / FCF | 13.2 | 14.3 | 14.4 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 8.3% | 4.3% | 3.4% | · | · | · | · | · | · | · | · | |
| Earnings Yield | -73.9% | -4.9% | -0.28% | -3.0% | -1.3% | -2.7% | 2.1% | 2.5% | 0.96% | -33.7% | · | |
| Payout Ratio | -11.2% | -88.8% | -1178.7% | -101.3% | -188.1% | -76.2% | 76.9% | 80.1% | 76.2% | -2.1% | · | |
| Annual Payout | $159M | $152M | $150M | $142M | $130M | $124M | $112M | $105M | $91M | $83M | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $969M | $1.11B | $1.04B | $1.06B | $1.04B | $1.14B | $1.09B | $1.07B | $1.08B | $1.16B | $1.12B | $1.18B | $1.16B | |
| Cost of Revenue | $709M | $644M | $747M | $666M | $693M | $652M | $752M | $683M | $671M | $724M | $730M | $713M | $768M | $773M | |
| Gross Profit | $314M | $326M | $362M | $377M | $363M | $392M | $386M | $404M | $395M | $358M | $427M | $411M | $414M | $383M | |
| R&D Expense | $24M | $25M | $22M | $25M | $22M | $27M | $28M | $26M | $29M | $29M | $30M | $30M | $31M | $33M | |
| SG&A Expense | $100M | $115M | $116M | $94M | $113M | $112M | $95M | $117M | $126M | $130M | $129M | $126M | $135M | $126M | |
| Operating Expenses | $290M | $698M | $1.65B | $304M | $318M | $345M | $272M | $324M | $421M | $413M | $443M | $349M | $365M | $352M | |
| Operating Income | $24M | $-372M | $-1.29B | $73M | $45M | $47M | $114M | $80M | $-26M | $-55M | $-16M | $62M | $48M | $31M | |
| Other Non-op | $120M | $6M | $-1M | $-10M | $-3M | $400.0K | $600.0K | $4M | $-3M | $-400.0K | $800.0K | $600.0K | $-500.0K | $-4M | |
| Pretax Income | $105M | $-408M | $-1.33B | $22M | $3M | $8M | $70M | $22M | $-74M | $-99M | $-54M | $19M | · | · | |
| Income Tax | $17M | $-19M | $83M | $10M | $4M | $8M | $112M | $39M | $32M | $-103M | $-27M | $4M | $5M | $-2M | |
| Net Income | $74M | $-399M | $-1.42B | $8M | $-8M | $-6M | $-44M | $-21M | $-108M | $2M | $-32M | $14M | $-3M | $-24M | |
| EPS (Basic) | $0.54 | $-2.87 | $-10.23 | $0.05 | $-0.06 | $-0.05 | $-0.32 | $-0.15 | $-0.79 | $0.01 | $-0.23 | $0.10 | $-0.02 | $-0.17 | |
| EPS (Diluted) | $0.53 | $-2.87 | $-10.23 | $0.05 | $-0.06 | $-0.05 | $-0.32 | $-0.15 | $-0.79 | $0.01 | $-0.23 | $0.10 | $-0.02 | $-0.17 | |
| Shares (Basic) | 139,100,000 | 138,700,000 | · | 138,500,000 | 138,200,000 | 137,700,000 | · | 137,500,000 | 137,100,000 | 136,600,000 | · | 135,500,000 | 134,900,000 | · | |
| Shares (Diluted) | 139,600,000 | 138,700,000 | · | 138,900,000 | 138,200,000 | 137,700,000 | · | 137,500,000 | 137,100,000 | 137,600,000 | · | 136,900,000 | 134,900,000 | · | |
| EBITDA | $24M | $-289M | · | $158M | $132M | $127M | · | $80M | $-26M | $26M | · | $62M | $137M | · |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $432M | $454M | $410M | · | $1.46B | $543M | $658M | · | $598M | $553M | · | |
| Receivables | $710M | $697M | $613M | $644M | $678M | $717M | $642M | $786M | $726M | $780M | · | $738M | $739M | · | |
| Inventory | $1.06B | $1.12B | $1.15B | $1.23B | $1.22B | $1.16B | $1.08B | $1.13B | $1.12B | $1.12B | · | $1.15B | $1.18B | · | |
| Prepaid Expense | $278M | $272M | $231M | $295M | $267M | $229M | $199M | $312M | $282M | $247M | · | $280M | $266M | · | |
| Current Assets | $2.45B | $2.71B | $2.80B | $2.88B | $2.62B | $2.53B | $2.48B | $3.71B | $2.96B | $2.81B | · | $2.77B | $2.74B | · | |
| PP&E (Net) | $849M | $878M | $899M | $903M | $914M | $913M | $918M | $909M | $910M | $911M | $916M | $903M | $919M | $926M | |
| Goodwill | $1.69B | $1.70B | $2.05B | $3.36B | $3.48B | $3.38B | $3.32B | $3.42B | $3.37B | $3.49B | $3.53B | $3.55B | $3.59B | $3.49B | |
| Intangibles | $4.55B | $4.58B | $4.76B | $4.74B | $4.94B | $4.66B | $4.50B | $4.81B | $4.71B | $4.92B | · | $4.85B | $4.94B | · | |
| Other Non-current Assets | $259M | $260M | $262M | $302M | $302M | $301M | $319M | $300M | $316M | $349M | · | $387M | $343M | · | |
| Total Assets | $7.61B | $7.98B | $8.54B | $10.08B | $10.09B | $9.76B | $9.65B | $11.20B | $10.40B | $10.64B | $10.81B | $10.76B | $10.95B | $11.02B | |
| Accounts Payable | $400M | $435M | $474M | $470M | $489M | $502M | $495M | $458M | $472M | $454M | · | $433M | $505M | · | |
| Accrued Liabilities | · | · | · | $363M | $328M | $254M | · | $227M | $218M | $359M | · | $262M | $272M | · | |
| Current Liabilities | $1.05B | $998M | $1.01B | $1.15B | $1.13B | $1.07B | $1.04B | $1.45B | $1.49B | $1.55B | · | $1.01B | $1.09B | · | |
| Capital Leases | $138M | $147M | $152M | $153M | $152M | $150M | $154M | $160M | $164M | $152M | · | $173M | $185M | · | |
| Deferred Tax | $147M | $154M | $169M | $194M | $207M | $189M | $203M | $214M | $212M | $248M | · | $349M | $334M | · | |
| Other Non-current Liabilities | $609M | $712M | $814M | $690M | $673M | $542M | $499M | $660M | $535M | $526M | · | $614M | $638M | · | |
| Total Liabilities | $5.09B | $5.48B | $5.60B | $5.64B | $5.62B | $5.40B | $5.33B | $6.64B | $5.85B | $5.95B | · | $6.02B | $6.12B | · | |
| Long-term Debt | $3.29B | $3.63B | $3.64B | $3.64B | $3.65B | $3.63B | $3.62B | $4.75B | $4.06B | $4.07B | · | $4.09B | $4.10B | · | |
| Total Debt | $3.29B | $3.63B | · | $3.64B | $3.65B | $3.63B | · | $4.75B | $4.06B | $4.07B | · | $4.09B | · | · | |
| Common Stock | $6.54B | $6.58B | $6.61B | $6.64B | $6.66B | $6.69B | $6.73B | $6.76B | $6.79B | $6.80B | · | $6.86B | $6.91B | · | |
| Retained Earnings | $-4.00B | $-4.08B | $-3.68B | $-2.26B | $-2.27B | $-2.26B | $-2.25B | $-2.21B | $-2.19B | $-2.08B | · | $-2.05B | $-2.07B | · | |
| AOCI | $-23M | $-3M | $5M | $70M | $75M | $-70M | $-162M | $10M | $-54M | $-38M | · | $-78M | $-6M | · | |
| Stockholders' Equity | $2.52B | $2.50B | $2.94B | $4.45B | $4.47B | $4.36B | $4.32B | $4.57B | $4.55B | $4.69B | $4.77B | $4.74B | $4.83B | $4.84B | |
| Liabilities + Equity | $7.61B | $7.98B | $8.54B | $10.08B | $10.09B | $9.76B | $9.65B | $11.20B | $10.40B | $10.64B | · | $10.76B | $10.95B | · | |
| Shares Outstanding | 138,700,000 | 138,100,000 | 137,600,000 | 137,600,000 | 137,600,000 | 137,200,000 | 136,500,000 | 136,500,000 | 136,400,000 | 136,300,000 | · | · | · | · |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $83M | $86M | $85M | $86M | $80M | $80M | $82M | $82M | $81M | $86M | $91M | $89M | $97M | |
| Stock-based Comp | $7M | $14M | $13M | $13M | $17M | $12M | $20M | $6M | $23M | $16M | $11M | $15M | $25M | $8M | |
| Deferred Tax | $-6M | $-13M | $-37M | $-24M | $13M | $-3M | $23M | $-15M | $12M | $-11M | $-119M | $14M | $-10M | $-31M | |
| Amort. of Intangibles | $54M | $54M | $56M | $56M | $57M | $55M | $55M | $58M | $58M | $58M | $63M | $68M | $65M | $74M | |
| Restructuring | $14M | $75M | $13M | $21M | $9M | $29M | $12M | $17M | $37M | $44M | $16M | $16M | $3M | $10M | |
| Other Non-cash | · | $4M | · | · | · | $-323M | · | · | · | $-216M | · | · | $-169M | · | |
| Operating Cash Flow | $83M | $-114M | $175M | $52M | $76M | $-64M | $313M | $42M | $10M | $-1M | $209M | $124M | $19M | $186M | |
| CapEx | $14M | $14M | $27M | $22M | $19M | $26M | $38M | $27M | $28M | $25M | $27M | $32M | $23M | $26M | |
| Investing Cash Flow | $349M | $-12M | $-24M | $-21M | $-4M | $-26M | $-37M | $213M | $-73M | $-24M | $-23M | $-31M | $-20M | $-26M | |
| Debt Issued | $0 | $428M | $0 | $0 | $0 | $0 | $-2M | · | · | · | $295M | $0 | · | $0 | |
| Net Debt Issued | · | $3M | · | · | · | $-9M | · | · | · | $-10M | · | · | · | · | |
| Dividends Paid | $40M | $40M | $40M | $40M | $39M | $41M | $40M | $38M | $38M | $38M | $38M | $39M | $36M | $35M | |
| Financing Cash Flow | $-389M | $-45M | $-54M | $-50M | $-54M | $-62M | $-1.15B | $653M | $-50M | $-60M | $-45M | $-43M | $-51M | $-42M | |
| Net Change in Cash | $40M | $-174M | $100M | $-20M | $37M | $-142M | $-905M | $921M | $-116M | $-93M | $153M | $43M | $-48M | $132M | |
| Free Cash Flow | · | $-127M | · | · | · | $-90M | · | · | · | $-26M | · | · | $-4M | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.7% | 33.6% | · | 36.1% | 34.4% | 37.6% | · | 37.2% | 37.0% | 33.1% | · | 36.6% | 35.0% | · | |
| Operating Margin | 2.3% | -38.4% | · | 7.0% | 4.3% | 4.5% | · | 7.4% | -2.5% | -5.1% | · | 5.5% | 4.1% | · | |
| Net Margin | 7.3% | -41.1% | · | 0.72% | -0.80% | -0.61% | · | -1.9% | -10.2% | 0.18% | · | 1.3% | -0.25% | · | |
| Pretax Margin | 10.3% | -42.1% | · | 2.1% | 0.30% | 0.80% | · | 2.0% | · | · | · | · | · | · | |
| EBITDA Margin | 2.3% | -29.8% | · | 15.1% | 12.5% | 12.2% | · | 7.4% | -2.5% | 2.4% | · | 5.5% | 11.6% | · | |
| ROA | 0.84% | -4.5% | · | 0.07% | -0.08% | -0.06% | · | -0.19% | -1.0% | 0.02% | · | 0.13% | · | · | |
| ROE | 2.1% | -11.6% | · | 0.17% | -0.19% | -0.14% | · | -0.45% | -2.3% | 0.04% | · | 0.30% | · | · | |
| ROIC | 0.34% | -5.8% | · | 0.51% | -0.09% | 0.01% | · | -0.70% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.7 | · | 2.5 | 2.3 | 2.4 | · | 2.6 | 2.0 | 1.8 | · | 2.7 | · | · | |
| Quick Ratio | 0.7 | 0.7 | · | 0.9 | 1.0 | 1.0 | · | 1.6 | 0.9 | 0.9 | · | 1.3 | · | · | |
| Debt / Equity | 1.3 | 1.5 | · | 0.8 | 0.8 | 0.8 | · | 1.0 | 0.9 | 0.9 | · | 0.9 | · | · | |
| LT Debt / Equity | 1.3 | 1.4 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.9 | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | · | · | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.6 | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.14 | $18.09 | · | $32.31 | $32.50 | $31.81 | · | $33.45 | $33.32 | $34.39 | · | · | · | · | |
| Revenue / Share | $7.33 | $6.99 | · | $7.51 | $7.64 | $7.58 | · | $7.91 | $7.77 | $7.86 | · | $8.21 | $8.76 | · | |
| Cash Flow / Share | · | $-0.82 | · | · | · | $-0.47 | · | · | · | $-0.01 | · | · | $0.14 | · | |
| Cash / Share | · | · | · | $3.14 | $3.30 | $2.99 | · | $10.72 | $3.98 | $4.83 | · | · | · | · | |
| Dividend / Share | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.27 | $0.27 | $0.27 | · | $0.26 | $0.26 | · | |
| EPS (TTM) | $-12.52 | $-13.11 | · | $-0.38 | $-0.58 | $-1.31 | · | $-1.16 | $-0.91 | $-0.06 | · | $-0.03 | $-1.04 | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.14B | $4.18B | · | $4.28B | $4.33B | $4.34B | · | $4.39B | $4.43B | $4.56B | · | $4.65B | $4.56B | · | |
| Net Income TTM | $-1.73B | $-1.82B | · | $-52M | $-80M | $-180M | · | $-160M | $-124M | $-8M | · | $-4M | $-141M | · | |
| Market Cap | $1.38B | $1.32B | · | $2.95B | $3.65B | $3.85B | · | $3.50B | $3.50B | $4.39B | · | · | · | · | |
| Enterprise Value | · | · | · | $6.16B | $6.85B | $7.07B | · | $6.79B | $7.02B | $7.79B | · | · | · | · | |
| P/E | -0.8 | -0.7 | · | -56.4 | -45.8 | -21.4 | · | -22.1 | -28.2 | -536.5 | · | -1065.0 | -34.5 | · | |
| P/S | 0.3 | 0.3 | · | 0.7 | 0.8 | 0.9 | · | 0.8 | 0.8 | 1.0 | · | · | · | · | |
| P/B | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | · | · | · | |
| P / Cash Flow | · | -11.6 | · | · | · | -59.7 | · | · | · | -3133.9 | · | · | · | · | |
| EV / Revenue | · | · | · | 1.4 | 1.6 | 1.6 | · | 1.5 | 1.6 | 1.7 | · | · | · | · | |
| Dividend Yield | 11.6% | 12.0% | · | 5.4% | 4.3% | 4.0% | · | 4.3% | 4.3% | · | · | · | · | · | |
| Earnings Yield | -125.8% | -137.6% | · | -1.8% | -2.2% | -4.7% | · | -4.5% | -3.5% | -0.19% | · | -0.09% | -2.9% | · | |
| Payout Ratio | · | -10.0% | · | · | · | -634.4% | · | · | · | 1880.0% | · | · | -1206.7% | · | |
| Annual Payout | $160M | $159M | · | $159M | $157M | $156M | · | $150M | $152M | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-04-02 |
|---|---|---|---|---|---|
| Gelir | $4.25B | $4.37B | $4.66B | $4.45B | · |
| Brüt Kâr Marjı % | 35.1% | 35.3% | 36.1% | 32.7% | · |
| Faaliyet Kâr Marjı % | -26.4% | 2.6% | 3.3% | 1.8% | · |
| Net Gelir | $-1.43B | $-172M | $-13M | $-141M | · |
| Seyreltilmiş Hisse Başı Kâr | $-10.29 | $-1.25 | $-0.09 | $-1.04 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-04-02 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 1.2 | 0.8 | 0.9 | 0.8 | · |
| Cari Oran | 2.8 | 2.4 | 1.8 | 2.4 | · |
| Cari Oran | 0.6 | 0.6 | 0.5 | 1.2 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-04-02 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $145M | $245M | $304M | $211M | · |
Kurumsal Sahipler (13F) 373 dosya · $1.8B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
373
Tutulan Değer
$1.8B
Yeni pozisyonlar
72
Çıkan pozisyonlar
51
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 72 (-4 önceki Ç'ye göre) | 51 (-8 önceki Ç'ye göre) | 126 (+20 önceki Ç'ye göre) | 98 (-13 önceki Ç'ye göre) | +15.8M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $235.885.493 | 22.703.127 | 12,75% | Hisse senetleri |
| VANGUARD GROUP INC | $208.568.497 | 14.983.369 | 11,27% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $110.966.239 | 10.680.100 | 6,00% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $93.984.418 | 9.045.661 | 5,08% | Hisse senetleri |
| STATE STREET CORP | $88.664.318 | 8.528.704 | 4,79% | Hisse senetleri |
| FULLER & THALER ASSET MANAGEMENT, INC. | $77.906.575 | 7.498.227 | 4,21% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $64.889.893 | 6.245.418 | 3,51% | Hisse senetleri |
| Invesco Ltd. | $60.955.034 | 5.866.702 | 3,30% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $56.799.503 | 5.467.098 | 3,07% | Hisse senetleri |
| MENORA MIVTACHIM HOLDINGS LTD. | $45.656.964 | 4.394.318 | 2,47% | Hisse senetleri |
| Ion Asset Management Ltd. | $39.195.200 | 1.760.000 | 2,12% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $37.643.256 | 3.622.308 | 2,03% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $35.259.152 | 3.480.666 | 1,91% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31.421.573 | 3.024.213 | 1,70% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $30.986.419 | 2.982.331 | 1,68% | Hisse senetleri |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $27.774.932 | 2.673.237 | 1,50% | Hisse senetleri |
| MORGAN STANLEY | $25.103.646 | 2.416.134 | 1,36% | Hisse senetleri |
| NORGES BANK | $20.928.483 | 2.014.291 | 1,13% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $19.537.003 | 1.880.366 | 1,06% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.490.269 | 1.875.868 | 1,05% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $18.093.426 | 1.741.427 | 0,98% | Hisse senetleri |
| NORTHERN TRUST CORP | $16.964.999 | 1.632.820 | 0,92% | Hisse senetleri |
| UBS Group AG | $16.198.945 | 1.559.090 | 0,88% | Hisse senetleri |
| Sound Income Strategies, LLC | $16.152.598 | 1.554.629 | 0,87% | Hisse senetleri |
| Man Group plc | $15.898.840 | 1.530.206 | 0,86% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $15.294.154 | 1.472.007 | 0,83% | Hisse senetleri |
| LPL Financial LLC | $14.870.860 | 1.431.267 | 0,80% | Hisse senetleri |
| Quantinno Capital Management LP | $14.231.562 | 1.369.736 | 0,77% | Hisse senetleri |
| GAMCO INVESTORS, INC. ET AL | $14.168.916 | 1.363.707 | 0,77% | Hisse senetleri |
| Cutter Capital Management, LP | $13.445.657 | 479.517 | 0,73% | Hisse senetleri |
| CastleKnight Management LP | $13.061.269 | 1.257.100 | 0,71% | Hisse senetleri |
| COOKE & BIELER LP | $12.350.271 | 1.188.669 | 0,67% | Hisse senetleri |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $12.029.275 | 1.157.773 | 0,65% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.943.263 | 1.149.496 | 0,65% | Hisse senetleri |
| Bank of New York Mellon Corp | $11.043.550 | 1.062.902 | 0,60% | Hisse senetleri |
| Keeley-Teton Advisors, LLC | $10.534.067 | 375.680 | 0,57% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $9.545.906 | 918.759 | 0,52% | Hisse senetleri |
| GABELLI FUNDS LLC | $9.084.590 | 874.359 | 0,49% | Hisse senetleri |
| O'Keefe Stevens Advisory, Inc. | $8.682.456 | 835.655 | 0,47% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $8.625.092 | 830.134 | 0,47% | Hisse senetleri |
| Blue Door Asset Management, LLC | $8.312.000 | 800.000 | 0,45% | Alım opsiyonu |
| Point72 Asset Management, L.P. | $7.409.867 | 713.173 | 0,40% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $6.948.509 | 668.769 | 0,38% | Hisse senetleri |
| ProShare Advisors LLC | $6.569.141 | 632.256 | 0,36% | Hisse senetleri |
| NICOLA WEALTH MANAGEMENT LTD. | $6.192.440 | 596.000 | 0,33% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $5.890.340 | 566.924 | 0,32% | Hisse senetleri |
| Trexquant Investment LP | $5.641.271 | 542.952 | 0,30% | Hisse senetleri |
| Empowered Funds, LLC | $5.471.987 | 526.659 | 0,30% | Hisse senetleri |
| Caption Management, LLC | $5.195.000 | 500.000 | 0,28% | Alım opsiyonu |
| Caption Management, LLC | $5.195.000 | 500.000 | 0,28% | Satım opsiyonu |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| STARBOARD VALUE LP, STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD, STARBOARD VALUE AND OPPORTUNITY S LLC, STARBOARD VALUE AND OPPORTUNITY C LP, STARBOARD VALUE R LP, STARBOARD VALUE R GP LLC, STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP, STARBOARD VALUE L LP, STARBOARD LEADERS KILO LLC, STARBOARD LEADERS FUND LP, STARBOARD LEADERS SELECT III LP, STARBOARD LEADERS SELECT III GP LLC, STARBOARD VALUE A LP, STARBOARD VALUE A GP LLC, STARBOARD VALUE GP LLC, STARBOARD PRINCIPAL CO LP, STARBOARD PRINCIPAL CO GP LLC, JEFFREY C. SMITH, PETER A. FELD ×3 başvurular | 16 Ağustos 2019 | · | İlk başvuru | · | SEC |
| Perrigo Company plc (2), Elan Corporation Limited (2), Elan Science One Limited (2) ×2 başvurular | 04 Şubat 2014 | · | İlk başvuru | Sermaye yapısı | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 64 içeriden öğrenenler · 35 yöneticiler · 30 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Albert Manzone | Interim President and CEO | 08 Temmuz 2026 A | 16.353 | 0 | 0 | $0 |
| Murray S Kessler | CEO | 11 Mayıs 2023 S | 2.668 | 0 | 0 | $0 |
| Uwe Roehrhoff | CEO | 08 Mart 2018 A | 7.500 | 0 | 0 | $0 |
| John T Hendrickson | CEO | 03 Kasım 2017 M | 8.442 | 0 | 0 | $0 |
| Joseph C Papa | CEO | 26 Şubat 2016 A | 118.515 | 0 | 0 | $0 |
| Eduardo Guarita Bezerra | EVP & Chief Financial Officer | 08 Temmuz 2026 A | 84.700 | 0 | 0 | $0 |
| Raymond Silcock | EVP, Chief Financial Officer | 05 Nisan 2022 M | 59.488 | 0 | 0 | $0 |
| Ronald Winowiecki | CFO | 22 Ağustos 2019 S | 6.952 | 0 | 0 | $0 |
| Judy L Brown | EVP, Business Ops & CFO | 25 Kasım 2016 S | 10.007 | 0 | 0 | $0 |
| David Ball | EVP & CBDO | 09 Eylül 2026 M | 11.664 | 0 | 0 | $0 |
| Matthew John Winterman | EVP, Supply, Ops, Strategy | 08 Temmuz 2026 A | 8.365 | 0 | 0 | $0 |
| Abigail Lennox | EVP and CSO | 08 Temmuz 2026 A | 4.607 | 0 | 0 | $0 |
| Charles Atkinson | EVP, General Counsel & Sec. | 08 Temmuz 2026 A | 5.855 | 0 | 0 | $0 |
| Roberto Khoury | EVP and President of CSCI | 08 Temmuz 2026 A | 14.113 | 0 | 0 | $0 |
| Robert Willis | EVP & CHRO | 08 Temmuz 2026 A | 50.568 | 0 | 0 | $0 |
| Triona Schmelter | EVP & President CSCA | 06 Haziran 2025 A | 6.670 | 0 | 0 | $0 |
| Ronald Craig Janish | EVP, Gbl Ops & SC & CTO | 06 Haziran 2025 A | 35.558 | 0 | 0 | $0 |
| Svend Andersen | EVP & President CHCI | 20 Ağustos 2024 S | 7.000 | 0 | 0 | $0 |
| Alison Ives | EVP & Chief Scientific Officer | 08 Temmuz 2024 M | 18.451 | 0 | 0 | $0 |
| Todd W Kingma | Executive VP, General Counsel | 07 Haziran 2024 A | 45.269 | 0 | 0 | $0 |
| Grainne Quinn | EVP, Chief Medical Officer | 05 Nisan 2024 A | 21.078 | 0 | 0 | $0 |
| Thomas Farrington | EVP and CIO | 05 Nisan 2024 A | 10.693 | 0 | 0 | $0 |
| Kyle Hanson | EVP & General Counsel | 05 Nisan 2024 A | 11.137 | 0 | 0 | $0 |
| James E Dillard III | EVP & President CSCA | 10 Mart 2023 S | 25.130 | 0 | 0 | $0 |
| Richard S Sorota | EVP & President CSCA | 05 Mart 2021 A | 11.161 | 0 | 0 | $0 |
| Sharon Kochan | EVP & President Rx | 05 Mart 2021 A | 38.748 | 0 | 0 | $0 |
| Jeffrey Needham | EVP, President CHC Americas | 29 Haziran 2020 M | 31.191 | 0 | 0 | $0 |
| John Wesolowski | EVP, President Rx | 26 Şubat 2019 M | 2.431 | 0 | 0 | $0 |
| Paul Weninger | EVP, Quality Operations | 26 Şubat 2019 M | 5.049 | 0 | 0 | $0 |
| James R Michaud | EVP, Chief HR Officer | 08 Ekim 2018 A | · | 0 | 0 | $0 |
| Marc Coucke | Executive VP & GM | 26 Şubat 2016 A | · | 0 | 0 | $0 |
| Douglas Boothe | EVP & GM Perrigo Pharma | 26 Şubat 2016 A | 803 | 0 | 0 | $0 |
| Jatin Shah | Sr VP & Chief Scientific Offic | 21 Ağustos 2015 M | 4.426 | 0 | 0 | $0 |
| Michael Robert Stewart | Sr. VP Global Human Resources | 21 Ağustos 2015 M | 1.236 | 0 | 0 | $0 |
| Louis Yu | Executive VP Global Quality | 21 Ağustos 2015 M | 6.152 | 0 | 0 | $0 |
| Geoffrey M. Parker | Yönetim kurulu üyesi | 11 Eylül 2026 M | 33.873 | 1 | 0 | $106.350 |
| Bradley Alford | Yönetim kurulu üyesi | 11 Eylül 2026 A | 46.121 | 0 | 0 | $0 |
| Muhammad Omer Gajial | Yönetim kurulu üyesi | 08 Temmuz 2026 A | · | 0 | 0 | $0 |
| Ahmed Salman Amin | Yönetim kurulu üyesi | 08 Temmuz 2026 A | · | 0 | 0 | $0 |
| Kevin Francis Egan | Yönetim kurulu üyesi | 14 Mayıs 2026 M | 3.798 | 0 | 0 | $0 |
| Jonas Samuelson | Yönetim kurulu üyesi | 14 Mayıs 2026 M | 5.392 | 0 | 0 | $0 |
| Julia M Brown | Yönetim kurulu üyesi | 14 Mayıs 2026 M | 11.832 | 0 | 0 | $0 |
| Donal O'Connor | Yönetim kurulu üyesi | 14 Mayıs 2026 M | 34.435 | 0 | 0 | $0 |
| Orlando D Ashford | Yönetim kurulu üyesi | 14 Mayıs 2026 M | 27.717 | 0 | 0 | $0 |
| Adriana Karaboutis | Yönetim kurulu üyesi | 14 Mayıs 2025 M | 27.629 | 0 | 0 | $0 |
| Jeffrey B Kindler | Yönetim kurulu üyesi | 14 Mayıs 2025 M | 10.559 | 0 | 0 | $0 |
| Katherine C. Doyle | Yönetim kurulu üyesi | 13 Eylül 2024 S | 6.009 | 0 | 0 | $0 |
| Erica L Mann | Yönetim kurulu üyesi | 15 Mayıs 2024 M | 17.458 | 0 | 0 | $0 |
| Theodore R. Samuels II | Yönetim kurulu üyesi | 17 Mayıs 2022 M | 26.693 | 0 | 0 | $0 |
| Rolf A Classon | Yönetim kurulu üyesi | 02 Aralık 2021 P | 17.442 | 0 | 0 | $0 |
| Smith Jeffrey C | Yönetim kurulu üyesi | 15 Mayıs 2019 M | 4.809 | 0 | 0 | $0 |
| Gary M Cohen | Yönetim kurulu üyesi | 14 Kasım 2018 M | 20.317 | 0 | 0 | $0 |
| Laurie Brlas | Yönetim kurulu üyesi | 06 Haziran 2018 M | 15.329 | 0 | 0 | $0 |
| JANDERNOA MICHAEL J | Yönetim kurulu üyesi | 15 Kasım 2016 G | 142.403 | 0 | 0 | $0 |
| Gary K Kunkle JR | Yönetim kurulu üyesi | 09 Eylül 2016 M | 25.687 | 0 | 0 | $0 |
| Herman Morris JR | Yönetim kurulu üyesi | 08 Eylül 2016 M | 9.352 | 0 | 0 | $0 |
| Shlomo Yanai | Yönetim kurulu üyesi | 19 Mayıs 2016 A | 443 | 0 | 0 | $0 |
| Ellen Randi Hoffing | Yönetim kurulu üyesi | 19 Mayıs 2016 A | 9.084 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Yönetim kurulu üyesi | 04 Mayıs 2016 M | 3.916 | 0 | 0 | $0 |
| Ran Gottfried | Yönetim kurulu üyesi | 19 Kasım 2015 M | 12.728 | 0 | 0 | $0 |
| David T Gibbons | Yönetim kurulu üyesi | 04 Kasım 2015 M | 14.178 | 0 | 0 | $0 |
| Patrick Lockwood-Taylor | · | 05 Haziran 2026 M | 123.170 | 0 | 0 | $0 |
| Scott F Jamison | · | 21 Ağustos 2015 M | 5.196 | 0 | 0 | $0 |
| Ben-Zion Zilberfarb | · | 18 Aralık 2013 A | 3.197 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 46 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PEY · Invesco Exchange-Traded Fund Trust | 3,83% | 2.780.929 SH | 01 Ekim 2026 | Günlük |
| PJP · Invesco Exchange-Traded Fund Trust | 3,27% | 1.234.781 SH | 01 Ekim 2026 | Günlük |
| DIV · Global X Funds | 1,37% | 1.064.713 NS | 31 Temmuz 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,10% | 133.377 SH | 01 Ekim 2026 | Günlük |
| PILL · Direxion Shares ETF Trust | 1,03% | 21.029 NS | 31 Temmuz 2026 | N-PORT |
| RZV · Invesco Exchange-Traded Fund Trust | 1,00% | 187.613 SH | 01 Ekim 2026 | Günlük |
| SDIV · Global X Funds | 0,93% | 1.121.000 NS | 31 Temmuz 2026 | N-PORT |
| IHE · iShares Trust | 0,43% | 512.153 SH | 11 Eylül 2026 | Günlük |
| CVAR · ETF Opportunities Trust | 0,43% | 18.133 NS | 31 Temmuz 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,28% | 366.080 SH | 01 Ekim 2026 | Günlük |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,15% | 293.607 SH | 19 Ağustos 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,13% | 21.318 SH | 01 Ekim 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,12% | 99.890 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,09% | 122.460 SH | 19 Ağustos 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,08% | 482.911 SH | 19 Ağustos 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,08% | 648.547 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,06% | 3.606.562 SH | 11 Eylül 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,06% | 821.335 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 67.426 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 810.165 SH | 19 Ağustos 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2.010.523 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,02% | 320.378 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.590.918 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,02% | 3.178.628 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,02% | 415.648 SH | 19 Ağustos 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 128.525 SH | 01 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 8.428 SH | 11 Eylül 2026 | Günlük |
| VYM · VANGUARD WHITEHALL FUNDS | 0,01% | 546.668 SH | 19 Ağustos 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,01% | 5.179 NS | 31 Temmuz 2026 | N-PORT |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,01% | 16.595 SH | 01 Ekim 2026 | Günlük |
| PFM · Invesco Exchange-Traded Fund Trust | 0,01% | 3.941 SH | 01 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,01% | 315.315 NS | 31 Temmuz 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,00% | 200.000 SH | 09 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,00% | 10.479 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 38.007 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 174.979 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.401.851 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 113.746 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.350 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,00% | 31.620 SH | 19 Ağustos 2026 | Günlük |
| IJR · iShares Trust | · | 8.444.789 SH | 10 Eylül 2026 | Günlük |
| IJS · iShares Trust | · | 1.232.185 SH | 08 Eylül 2026 | Günlük |
| IWN · iShares Trust | · | 1.323.382 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 5.968 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 29.203 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 195.634 SH | 11 Eylül 2026 | Günlük |
PRGO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 10 analist
AL
Medyan hedef
$16.00
+12,2%
2 20,0%
Güçlü Al
4 40,0%
Al
4 40,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
4 analist · 2026-10-03Ortalama hedef $16.50 +15,7%
Şimdi
Mevcut fiyat $14.26
Düşük$14.00
Ortalama$16.50
Yüksek$20.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026